Pharmacy Benefit Management Acquisition

We served as lead healthcare regulatory counsel, as well as provided antitrust, employee benefits and tax support, for a leading provider of 340B Drug Pricing Program services in its acquisition by a prescription benefit management subsidiary (PBM) of a leading pharmacy healthcare provider.

You Also May Be Interested In:

  • Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019.┬áSerco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.

    We represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation's Naval Systems Business...
    Client Type: Private Company
  • Defended clients against roughly $26 million in ACA employer mandate penalties

    We have successfully defended our clients against roughly $26 million in ACA employer mandate penalties, which relate to the ACA...
    Client Type: Private Company
  • Represented a civil engineering company in establishing an ESOP, successfully acquiring 49% of the company in a leveraged transaction in the amount of $6.6 million

    We represented a civil engineering company in establishing an Employee Stock Ownership Plan (ESOP) and successfully acquiring 49% of the...
    Client Type: Private Company